N-[amino(imino)methyl]morpholine-4-carboximidamide hydrochloride, 95.0%, 500g

5-Methyl-2-(3-trifluoromethyl-phenyl)-2,4-dihydro-pyrazol-3-one, 250mg

4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95.0%, 5g

3-(2-methoxyphenyl)-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 1g

2-(Trifluoromethoxy)fluorobenzene, 97.0%, 1g

Methyl 1-(4-chlorophenyl)-3-oxocyclobutane-1-carboxylate, 97%, 1g

2-Methoxy-4-(methylsulfanyl)pyridine, 95+%, 500mg

4-(2-oxopiperidin-1-yl)butanoic acid, 95.0%, 1g

3-(Benzyl(methyl)amino)propane-1,2-diol, 97%, 100mg

5-Hydroxyisophthalamide, 95.0%, 250mg

(S)-7-Hydroxy-5-methoxy-2-phenylchroman-4-one, 95.0%, 1g

3-(DIBUTYLAMINO)PROPYL 4-HYDROXYBENZOATE (HCL), 95%, 5g

Thallium AAS standard solution, ROTI®Star, 500 ml, HDPE